Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI study-Reference-Cited by-同舟云学术

Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI study

Published:2018-12 Issue: Volume:273 Page:8-14
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

De Luca Leonardo,Piscione Federico^ORCID,Colivicchi Furio,Lucci Donata^ORCID,Mascia Franco,Marinoni Barbara,Cirillo Plinio^ORCID,Grosseto Daniele^ORCID,Mauro Ciro,Calabrò Paolo,Nardi Federico^ORCID,Rossini Roberta^ORCID,Geraci Giovanna,Gabrielli Domenico^ORCID,Di Lenarda Andrea,Gulizia Michele Massimo

Funder

Heart Care Foundation

AstraZeneca

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis;Bhatt;JAMA,2010

2. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective;Jernberg;Eur. Heart J.,2015

3. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation;Ibanez;Eur. Heart J.,2018

4. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;Roffi;Eur. Heart J.,2016

5. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction;Shore;Heart,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular prevention;European Heart Journal Supplements;2024-04

2. Who may benefit from low-dose Rivaroxaban plus Aspirin? Practical implications for outpatients with cardiovascular disease;Polish Archives of Internal Medicine;2023-09-21

3. European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction;Advances in Therapy;2022-10-26

4. Incidence, Characteristics, and Management of Patients with Recurrent Myocardial Infarctions: Insights from the EYESHOT POST-MI;Journal of Interventional Cardiology;2022-03-18

5. Predictors of adherence to composite therapy after acute coronary syndromes;Journal of Cardiovascular Medicine;2021-05-06